- Home
- NEXN vs XNCR Comparison
NEXN vs XNCR Comparison
Compare NEXN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXN
- XNCR
- Stock Information
- Founded
- NEXN 2007
- XNCR 1997
- Country
- NEXN Israel
- XNCR United States
- Employees
- NEXN N/A
- XNCR N/A
- Industry
- NEXN Computer Software: Programming Data Processing
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- NEXN Technology
- XNCR Health Care
- Exchange
- NEXN Nasdaq
- XNCR Nasdaq
- Market Cap
- NEXN 669.0M
- XNCR 547.8M
- IPO Year
- NEXN 2021
- XNCR 2013
- Fundamental
- Price
- NEXN $10.17
- XNCR $8.41
- Analyst Decision
- NEXN Strong Buy
- XNCR Buy
- Analyst Count
- NEXN 9
- XNCR 9
- Target Price
- NEXN $13.50
- XNCR $25.00
- AVG Volume (30 Days)
- NEXN 390.9K
- XNCR 718.6K
- Earning Date
- NEXN 08-13-2025
- XNCR 08-06-2025
- Dividend Yield
- NEXN N/A
- XNCR N/A
- EPS Growth
- NEXN N/A
- XNCR N/A
- EPS
- NEXN 0.75
- XNCR N/A
- Revenue
- NEXN $371,746,000.00
- XNCR $146,929,000.00
- Revenue This Year
- NEXN $5.43
- XNCR N/A
- Revenue Next Year
- NEXN N/A
- XNCR $28.84
- P/E Ratio
- NEXN $12.78
- XNCR N/A
- Revenue Growth
- NEXN 9.65
- XNCR N/A
- 52 Week Low
- NEXN $6.93
- XNCR $6.92
- 52 Week High
- NEXN $12.60
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- NEXN 53.43
- XNCR 55.89
- Support Level
- NEXN $9.07
- XNCR $7.13
- Resistance Level
- NEXN $10.65
- XNCR $7.99
- Average True Range (ATR)
- NEXN 0.52
- XNCR 0.53
- MACD
- NEXN 0.01
- XNCR 0.06
- Stochastic Oscillator
- NEXN 69.84
- XNCR 94.90
About NEXN Nexxen International Ltd. American Depository Shares
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.